SeaStar Medical Holding Corp - 8-K Filing

FDA determines QUELIMMUNE Pediatric SAVE Surveillance Registry has fulfilled post-approval study requirements for pediatric sepsis-associated AKI treatment. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ICU

Read the full article at SEC EDGAR

More Regulatory news